Drugs Associated with Abdominal Pain Side Effect


Although all health products are carefully tested before they are licensed for sale, they can carry various risks. Some side effects may only become evident after a product is in use by the general population.

The following drugs are associated with Abdominal Pain (click on the link below to view detailed reports):

Drug Name Abdominal Pain Reports All Reports
Humira 3316 272927
Mirena 3195 95929
Vioxx 1004 163906
Accutane 973 79755
Remicade 866 88892
Heparin 756 35697
Byetta 668 119951
Enbrel 666 266818
Fosamax 632 108140
Tecfidera 588 38299
Cimzia 411 13242
Tysabri 398 196525
Nexavar 384 35792
Seroquel 378 83831
Paragard 355 10045
Exjade 350 22177
Chantix 341 102562
Nexium 338 64024
Alli 329 18892
Forteo 295 61427
Bevacizumab 271 15525
Avastin 268 23862
Crestor 264 41860
Avonex 258 158045
Zelnorm 257 9010
Oxycontin 238 19974
Ibuprofen 237 22395
Zometa 234 44191
Nuvaring 225 24560
Sutent 223 30373
Gleevec 222 19929
Aspirin 218 28632
Cymbalta 218 42505
Lupron 216 13302
Sorafenib 216 12590
Aleve 215 26169
Rebif 213 61131
Victoza 210 18772
Revlimid 206 67826
Aredia 201 17968
1 of 68  View All


DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Abdominal Pain Reports Submitted to FDA

The following Abdominal Pain Side Effect Reports were submitted to FDA by healthcare professionals (physicians, pharmacists, and nurses), consumers (patients, family members, and lawyers) and manufacturers.

This information could help you understand how symptoms, such as Abdominal Pain could occur, develop and what you can do about them.

Renal Mass, Testicular Malignant Teratoma Stage Iii, Weight Decreased, Surgery, Abdominal Pain, Sepsis, Vomiting, Skeletal Injury

This is a report of a patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: psoriatic arthropathy,attention deficit/hyperactivity disorder, who was treated with Humira (dosage: NA, start time: Jan 01, 2008), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Renal Mass
  • Testicular Malignant Teratoma Stage Iii
  • Weight Decreased
  • Surgery
  • Abdominal Pain
  • Sepsis
  • Vomiting
  • Skeletal Injury
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Humira treatment in patients, resulting in Abdominal Pain side effect. The patient was hospitalized.
Abdominal Pain, Device Expulsion

This report suggests a potential Mirena Abdominal Pain, Device Expulsion side effect(s) that can have serious consequences. A 35-year-old female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: contraception and used Mirena (dosage: 20 Mcg/24hr, Cont) starting Jun 12, 2012. Soon after starting Mirena the patient began experiencing various side effects, including:
  • Abdominal Pain
  • Device Expulsion
Drugs used concurrently: NA. Although Mirena demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Abdominal Pain, may still occur.
Abdominal Pain, Duodenitis, Wound Drainage, Anosmia, Iritis, Prostatic Disorder, Change Of Bowel Habit, Blood Disorder, Pseudarthrosis

This Abdominal Pain, Duodenitis, Wound Drainage, Anosmia, Iritis, Prostatic Disorder, Change Of Bowel Habit, Blood Disorder, Pseudarthrosis problem was reported by a physician from UNITED STATES. A 46-year-old patient (weight: NA) was diagnosed with the following symptoms/conditions: ankylosing spondylitis,osteoporosis. On Apr 01, 2000 this consumer started treatment with Vioxx (dosage: NA). The following drugs were being taken at the same time:
  • Fosamax
When commencing Vioxx, the patient experienced the following unwanted symptoms/side effects:
  • Abdominal Pain
  • Duodenitis
  • Wound Drainage
  • Anosmia
  • Iritis
  • Prostatic Disorder
  • Change Of Bowel Habit
  • Blood Disorder
  • Pseudarthrosis
The patient was hospitalized and became disabled.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Abdominal Pain, may become evident only after a product is in use by the general population.
Pain, Dyspnoea, Injury, Pleuritic Pain, Abdominal Pain, Cerebrovascular Accident, Pulmonary Embolism, Cholelithiasis, Thrombosis

This is a report of a 22-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: acne and was treated with Accutane (dosage: Unk) starting Jul 24, 2007. Concurrently used drugs:
  • Yaz (Unk)
  • Yaz
Soon after that, the consumer experienced the following side effects:
  • Pain
  • Dyspnoea
  • Injury
  • Pleuritic Pain
  • Abdominal Pain
  • Cerebrovascular Accident
  • Pulmonary Embolism
  • Cholelithiasis
  • Thrombosis
The patient was hospitalized. This opens a possibility that Accutane treatment could cause the above reactions, including Abdominal Pain, and some female subjects may be more susceptible.
Muscle Twitching, Flushing, Pruritus, Nausea, Back Pain, Muscle Spasms, Abdominal Pain, Vomiting, Infusion Related Reaction

A female patient (weight: NA) from CANADA with the following symptoms/conditions: crohn's disease started Remicade treatment (dosage: NA) on Dec 08, 2011. Soon after starting Remicade treatment, the subject experienced various side effects, including:
  • Muscle Twitching
  • Flushing
  • Pruritus
  • Nausea
  • Back Pain
  • Muscle Spasms
  • Abdominal Pain
  • Vomiting
  • Infusion Related Reaction
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Remicade.
Dyspnoea, Myalgia, Inflammation, Abdominal Pain, Pyrexia, Application Site Erythema

A 16-year-old female patient from JAPAN (weight: NA) experienced symptoms, such as: intravenous catheter management and was treated with Heparin(dosage: X1;iv). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Dyspnoea
  • Myalgia
  • Inflammation
  • Abdominal Pain
  • Pyrexia
  • Application Site Erythema
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Heparin efficacy:
  • Infliximab
Blood Glucose Increased, Cholelithiasis, Abdominal Pain, Urinary Tract Infection, Gallbladder Polyp, Pancreatitis, Back Pain, Glycosylated Haemoglobin Increased, Gallbladder Enlargement

In this report, Byetta was administered for the following condition: type 2 diabetes mellitus,mineral supplementation,gastrooesophageal reflux disease.A female consumer from UNITED STATES (weight: NA) started Byetta treatment (dosage: 5 Ug, Bid) on May 02, 2012.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Blood Glucose Increased
  • Cholelithiasis
  • Abdominal Pain
  • Urinary Tract Infection
  • Gallbladder Polyp
  • Pancreatitis
  • Back Pain
  • Glycosylated Haemoglobin Increased
  • Gallbladder Enlargement
A possible interaction with other drugs could have contributed to this reaction:
  • Klor-con (10 Meq, Qd)
  • Nexium (40 Mg, Qd)
  • Calcium (Unk)
  • Benicar (20 Mg, Each Evening)
  • Meloxicam (15 Mg, Qd)
  • Metoprolol (75 Mg, Bid)
  • Vitamin Tab (Unk)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Byetta treatment could be related to the listed above side effect(s).
Gallbladder Disorder, Injection Site Pain, Gastrooesophageal Reflux Disease, Abdominal Pain

This is a report of the following Enbrel side effect(s):
  • Gallbladder Disorder
  • Injection Site Pain
  • Gastrooesophageal Reflux Disease
  • Abdominal Pain
A 66-year-old female patient from UNITED STATES (weight: NA) presented with the following condition: rheumatoid arthritis and received a treatment with Enbrel (dosage: 50 Mg, Qwk) starting: Sep 01, 2004.The following concurrently used drugs could have generated interactions: NA.The patient was hospitalized.This report suggests that a Enbrel treatment could be associated with the listed above side effect(s).
Mitral Valve Incompetence, Vertigo, Bundle Branch Block Left, Oesophagitis, Abdominal Pain Upper, Accelerated Hypertension, Procedural Haemorrhage

This Fosamax Plus D report was submitted by a 53-year-old female consumer from UNITED STATES (weight: NA). The patient was diagnosed with: osteoporosis and Fosamax Plus D was administered (dosage: NA) starting: Jan 01, 2011. The consumer developed a set of symptoms:
  • Mitral Valve Incompetence
  • Vertigo
  • Bundle Branch Block Left
  • Oesophagitis
  • Abdominal Pain Upper
  • Accelerated Hypertension
  • Procedural Haemorrhage
Other drugs used simultaneously: NA.The patient was hospitalized.Those unexpected symptoms could be linked to a Fosamax Plus D treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

This is a report of a possible correlation between use and the following symptoms/side effect(s):
    which could contribute to an assessment of risk profile.A consumer from (weight: NA) was suffering from NA and was treated with (dosage: NA) starting NS.Other concurrent medications: NA.
    Abdominal Pain, Pancreatitis

    A 47-year-old female patient from UNITED STATES (weight: NA) presented with the following symptoms: crohn's disease and after a treatment with Cimzia (dosage: At Week 0,2,4) experienced the following side effect(s):
    • Abdominal Pain
    • Pancreatitis
    The treatment was started on Jan 01, 2012. Cimzia was used in combination with the following drugs:
    • Folic Acid (Nr)
    The patient was hospitalized.This report could alert potential Cimzia consumers.
    Insomnia, Abdominal Pain Upper, Weight Decreased, Hepatic Failure, Gastritis, Decreased Appetite, Fatigue, Depressed Mood

    In this report, a 52-year-old female patient from UNITED STATES (weight: NA) was affected by a possible Tysabri side effect.The patient was diagnosed with multiple sclerosis. After a treatment with Tysabri (dosage: NA, start date: Jan 21, 2010), the patient experienced the following side effect(s):
    • Insomnia
    • Abdominal Pain Upper
    • Weight Decreased
    • Hepatic Failure
    • Gastritis
    • Decreased Appetite
    • Fatigue
    • Depressed Mood
    The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Tysabri treatment.
    Abdominal Pain

    This is a report of a 66-year-old patient from UNITED STATES (weight: NA), who used Nexavar (dosage: 400 Mg, Bid) for a treatment of hepatic neoplasm malignant. After starting a treatment on Jan 04, 2012, the patient experienced the following side effect(s):
    • Abdominal Pain
    The following drugs could possibly have interacted with the Nexavar treatment NA.The patient was hospitalized.Taken together, these observations suggest that a Nexavar treatment could be related to side effect(s), such as Abdominal Pain.
    Gastrointestinal Neoplasm, Abdominal Pain

    This Abdominal Pain side effect was reported by a health professional from CANADA. A 54-year-old female patient (weight:NA) experienced the following symptoms/conditions: bipolar disorder. The patient was prescribed Seroquel Xr (dosage: NA), which was started on Oct 01, 2010. Concurrently used drugs:
    • Clonazepam
    • Paroxetine
    • Synthroid
    When starting to take Seroquel Xr the consumer reported the following symptoms:
    • Gastrointestinal Neoplasm
    • Abdominal Pain
    These side effects may potentially be related to Seroquel Xr.
    Maternal Exposure During Pregnancy, Pregnancy With Contraceptive Device, Menometrorrhagia, Constipation, Abdominal Pain

    This is a Paragard T 380a side effect report of a 27-year-old female patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: contraception, who was treated with Paragard T 380a (dosage:Paragard, start time: Apr 01, 2008), combined with: NA., and developed a serious reaction and a Abdominal Pain side effect. The patient presented with:
    • Maternal Exposure During Pregnancy
    • Pregnancy With Contraceptive Device
    • Menometrorrhagia
    • Constipation
    • Abdominal Pain
    which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Paragard T 380a treatment in female patients suffering from contraception, resulting in Abdominal Pain.
    Abdominal Pain, Nausea

    This report suggests a potential Exjade Abdominal Pain side effect(s) that can have serious consequences. A 76-year-old female patient from US (weight:NA) was diagnosed with the following health condition(s): iron overload,myelodysplastic syndrome and used Exjade (dosage: 1500 Mg, Qd, Oral;) starting 200710. Soon after starting Exjade the patient began experiencing various side effects, including:
    • Abdominal Pain
    • Nausea
    Drugs used concurrently:NA. Although Exjade demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Abdominal Pain, may still occur.
    Abdominal Pain, Headache, Suprapubic Pain, Tongue Disorder, Visual Field Defect

    This Abdominal Pain problem was reported by a health professional from UNITED STATES. A 57-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): nicotine dependence.On Apr 01, 2009 a consumer started treatment with Chantix (dosage: 0.5 Mg, 2x/day, Oral). The following drugs/medications were being taken at the same time: NA. When commencing Chantix, the patient experienced the following unwanted symptoms /side effects:
    • Abdominal Pain
    • Headache
    • Suprapubic Pain
    • Tongue Disorder
    • Visual Field Defect
    Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Abdominal Pain, may become evident only after a product is in use by the general population.
    Nausea, Abdominal Distension, Diarrhoea, Abdominal Pain, Dizziness

    This is a Nexium side effect report of a 44-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: gastrooesophageal reflux disease,gastrointestinal disorder and was treated with Nexium (dosage: 1 Capsule -40 Mg- Twice A Day Po) starting Jun 07, 2012. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
    • Nausea
    • Abdominal Distension
    • Diarrhoea
    • Abdominal Pain
    • Dizziness
    This opens a possibility that Nexium could cause Abdominal Pain and that some female patients may be more susceptible.
    Abdominal Pain, Loss Of Consciousness, Mobility Decreased, Muscle Strain, Malaise, Hyperhidrosis, Diarrhoea

    A 80-year-old female patient (weight: NA) from UNITED STATES with the following symptoms: weight loss diet started Alli treatment (dosage: 1cap Single Dose) on Jan 08, 2012. Soon after starting Alli treatment, the consumer experienced several side effects, including:
    • Abdominal Pain
    • Loss Of Consciousness
    • Mobility Decreased
    • Muscle Strain
    • Malaise
    • Hyperhidrosis
    • Diarrhoea
    . Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Alli side effects, such as Abdominal Pain.
    Cholelithiasis, Abdominal Pain, Intra-abdominal Haematoma, Pain In Extremity

    This Abdominal Pain side effect was reported by a physician from FRANCE. A 70-year-old female patient (weight:NA) experienced the following symptoms/conditions: osteoporosis.The patient was prescribed Forteo (dosage: 20 Ug, Qd), which was started on Jun 16, 2011. Concurrently used drugs: NA..When starting to take Forteo the consumer reported symptoms, such as:
    • Cholelithiasis
    • Abdominal Pain
    • Intra-abdominal Haematoma
    • Pain In Extremity
    These side effects may potentially be related to Forteo.
    White Blood Cell Count Decreased, Abdominal Pain, Fatigue, Large Intestine Perforation, Lung Infection, Lymphocyte Count Decreased

    This is a report of a female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: non-small cell lung cancer, who was treated with Bevacizumab (dosage: Over 30-90 Min On Day 1, On 28-may-2009, Removed From Protocol., start time: May 11, 2009), combined with:
    • Cisplatin (Over 60min Day1; On 28-may-2009, Removed From Protocol.)
    • Gemcitabine Hydrochloride (Days 1 And 8; On 28-may-2009, Removed From Protocol.)
    and developed a serious reaction and side effect(s). The consumer presented with:
    • White Blood Cell Count Decreased
    • Abdominal Pain
    • Fatigue
    • Large Intestine Perforation
    • Lung Infection
    • Lymphocyte Count Decreased
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bevacizumab treatment in female patients, resulting in Abdominal Pain side effect. The patient was hospitalized.
    Renal Failure Acute, Vomiting, Anaemia, Hypocalcaemia, Hypokalaemia, Fatigue, Abdominal Pain, White Blood Cell Count Decreased, Hypertension

    This report suggests a potential Avastin Renal Failure Acute, Vomiting, Anaemia, Hypocalcaemia, Hypokalaemia, Fatigue, Abdominal Pain, White Blood Cell Count Decreased, Hypertension side effect(s) that can have serious consequences. A 63-year-old patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: metastatic neoplasm and used Avastin (dosage: Over 30-90 Min, Day 1. Last Dose 30/11/2011, Total Dose Given This Course 1485mg) starting Jul 07, 2011. Soon after starting Avastin the patient began experiencing various side effects, including:
    • Renal Failure Acute
    • Vomiting
    • Anaemia
    • Hypocalcaemia
    • Hypokalaemia
    • Fatigue
    • Abdominal Pain
    • White Blood Cell Count Decreased
    • Hypertension
    Drugs used concurrently:
    • Docetaxel (Over 1 Hr, Day 1)
    • Cisplatin (Over 1-2 Hrs, Day 1)
    The patient was hospitalized. Although Avastin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Abdominal Pain, may still occur.
    Diverticulitis, Vomiting, Weight Decreased, Food Intolerance, Abdominal Pain, Off Label Use

    This Diverticulitis, Vomiting, Weight Decreased, Food Intolerance, Abdominal Pain, Off Label Use problem was reported by a consumer or non-health professional from UNITED STATES. A 56-year-old patient (weight: NA) was diagnosed with the following symptoms/conditions: angina pectoris. On NS this consumer started treatment with Crestor (dosage: NA). The following drugs were being taken at the same time:
    • Coreg
    When commencing Crestor, the patient experienced the following unwanted symptoms/side effects:
    • Diverticulitis
    • Vomiting
    • Weight Decreased
    • Food Intolerance
    • Abdominal Pain
    • Off Label Use
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Abdominal Pain, may become evident only after a product is in use by the general population.
    Abdominal Pain, Cystitis, Mobility Decreased

    This is a report of a 56-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: multiple sclerosis and was treated with Avonex (dosage: NA) starting Sep 01, 2003. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
    • Abdominal Pain
    • Cystitis
    • Mobility Decreased
    The patient was hospitalized. This opens a possibility that Avonex treatment could cause the above reactions, including Abdominal Pain, and some female subjects may be more susceptible.
    Abdominal Discomfort, Abdominal Distension, Abdominal Pain, Breast Cancer, Cyst, Cyst Aspiration, Diarrhoea, Dysarthria, Face Oedema

    A female patient (weight: NA) from UNITED STATES with the following symptoms/conditions: irritable bowel syndrome,abdominal distension started Zelnorm treatment (dosage: Unk) on Jan 01, 2003. Soon after starting Zelnorm treatment, the subject experienced various side effects, including:
    • Abdominal Discomfort
    • Abdominal Distension
    • Abdominal Pain
    • Breast Cancer
    • Cyst
    • Cyst Aspiration
    • Diarrhoea
    • Dysarthria
    • Face Oedema
    Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Zelnorm.
    Vomiting, Abdominal Pain, Pancreatitis, Diarrhoea

    A patient from UNITED STATES (weight: NA) experienced symptoms, such as: pain and was treated with Oxycontin(dosage: 160 Mg, Q12h). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
    • Vomiting
    • Abdominal Pain
    • Pancreatitis
    • Diarrhoea
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Oxycontin efficacy: NA.The patient was hospitalized.
    Faeces Discoloured, Abdominal Pain, Toxicity To Various Agents, Aspartate Aminotransferase Increased, Laboratory Test Abnormal, Jaundice, Gamma-glutamyltransferase Increased, Blood Alkaline Phosphatase Increased, Hyperbilirubinaemia

    In this report, Ibuprofen was administered for the following condition: back pain.A 52-year-old female consumer from GERMANY (weight: NA) started Ibuprofen treatment (dosage: 1800 Df, As Needed. 1x/day) on Jul 01, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Faeces Discoloured
    • Abdominal Pain
    • Toxicity To Various Agents
    • Aspartate Aminotransferase Increased
    • Laboratory Test Abnormal
    • Jaundice
    • Gamma-glutamyltransferase Increased
    • Blood Alkaline Phosphatase Increased
    • Hyperbilirubinaemia
    A possible interaction with other drugs could have contributed to this reaction:
    • Flupirtine Maleate (400 Mg, 1x/day)
    The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Ibuprofen treatment could be related to the listed above side effect(s).
    Metastases To Liver, Hepatic Pain, Abdominal Pain

    This is a report of the following Zometa side effect(s):
    • Metastases To Liver
    • Hepatic Pain
    • Abdominal Pain
    A female patient from NETHERLANDS (weight: NA) presented with the following condition: breast cancer metastatic and received a treatment with Zometa (dosage: 4 Mg, / 100ml Once In 28 Days) starting: May 11, 2012.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Zometa treatment could be associated with the listed above side effect(s).
    Thrombophlebitis, Soft Tissue Injury, Abdominal Pain, Pelvic Pain, Ovarian Cyst, Cerebral Venous Thrombosis, Weight Decreased, Blood Potassium Decreased, Coagulation Factor Viii Level Increased

    This Nuvaring report was submitted by a 31-year-old female consumer from UNITED STATES (weight: NA). The patient was diagnosed with: contraception and Nuvaring was administered (dosage: 1 Df;) starting: Apr 01, 2006. The consumer developed a set of symptoms:
    • Thrombophlebitis
    • Soft Tissue Injury
    • Abdominal Pain
    • Pelvic Pain
    • Ovarian Cyst
    • Cerebral Venous Thrombosis
    • Weight Decreased
    • Blood Potassium Decreased
    • Coagulation Factor Viii Level Increased
    Other drugs used simultaneously:
    • Toprol-xl
    • Restoril
    The patient was hospitalized.Those unexpected symptoms could be linked to a Nuvaring treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.
    Renal Failure Acute, Cardiac Failure, Cytolytic Hepatitis, Bradycardia, Ovarian Mass, Abdominal Pain, Lactic Acidosis, Leukocytosis, Hyperkalaemia

    This is a report of a possible correlation between Sutent use and the following symptoms/side effect(s):
    • Renal Failure Acute
    • Cardiac Failure
    • Cytolytic Hepatitis
    • Bradycardia
    • Ovarian Mass
    • Abdominal Pain
    • Lactic Acidosis
    • Leukocytosis
    • Hyperkalaemia
    which could contribute to an assessment of Sutent risk profile.A female consumer from FRANCE (weight: NA) was suffering from pancreatic neuroendocrine tumour,diabetes mellitus and was treated with Sutent (dosage: 25 Mg, 1x/day) starting Sep 01, 2010.Other concurrent medications:
    • Metformin Hcl (Unk)
    The patient was hospitalized.
    Ileitis, Diarrhoea, Hypercoagulation, Hypoacusis, Dyspnoea, Arthralgia, Cough, Inflammatory Bowel Disease, Abdominal Pain

    A 54-year-old female patient from US (weight: NA) presented with the following symptoms: chronic myeloid leukaemia,chromosome analysis abnormal and after a treatment with Gleevec (dosage: NA) experienced the following side effect(s):
    • Ileitis
    • Diarrhoea
    • Hypercoagulation
    • Hypoacusis
    • Dyspnoea
    • Arthralgia
    • Cough
    • Inflammatory Bowel Disease
    • Abdominal Pain
    The treatment was started on Aug 19, 2010. Gleevec was used in combination with the following drugs: NA.The patient was hospitalized.This report could alert potential Gleevec consumers.
    Oesophagitis, Gastrointestinal Disorder, Abdominal Pain, Intestinal Obstruction, Glucose Tolerance Impaired, Blood Iron Decreased, Blood Testosterone Decreased

    In this report, a patient from UNITED STATES (weight: NA) was affected by a possible Aspirin side effect.The patient was diagnosed with coagulopathy,blood cholesterol increased,gastrooesophageal reflux disease. After a treatment with Aspirin (dosage: Form Strength: 81 Milligrams, start date: Jun 18, 2012), the patient experienced the following side effect(s):
    • Oesophagitis
    • Gastrointestinal Disorder
    • Abdominal Pain
    • Intestinal Obstruction
    • Glucose Tolerance Impaired
    • Blood Iron Decreased
    • Blood Testosterone Decreased
    The following simultaneously used drugs could have led to this reaction:
    • Omega Fish Oil
    • Prevacid
    • Folic Acid
    • Crestor
    • Azor (40-5 Mg)
    • Tricor
    • Androgel (One Packet)
    • Flomax
    The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Aspirin treatment.
    Genital Pain, Abdominal Pain, Neoplasm Malignant, Colitis, Abdominal Distension, Dyspepsia, Weight Increased, Flatulence, Dysphagia

    This is a report of a female patient from BRAZIL (weight: NA), who used Cymbalta (dosage: NA) for a treatment of depression. After starting a treatment on Jan 01, 2007, the patient experienced the following side effect(s):
    • Genital Pain
    • Abdominal Pain
    • Neoplasm Malignant
    • Colitis
    • Abdominal Distension
    • Dyspepsia
    • Weight Increased
    • Flatulence
    • Dysphagia
    The following drugs could possibly have interacted with the Cymbalta treatment NA.Taken together, these observations suggest that a Cymbalta treatment could be related to side effect(s), such as Genital Pain, Abdominal Pain, Neoplasm Malignant, Colitis, Abdominal Distension, Dyspepsia, Weight Increased, Flatulence, Dysphagia.
    Diarrhoea, Myositis, Injection Site Abscess, Abdominal Pain

    This Abdominal Pain side effect was reported by a physician from UNITED STATES. A female patient (weight:NA) experienced the following symptoms/conditions: precocious puberty. The patient was prescribed Lupron Depot-ped (dosage: NA), which was started on Jun 01, 2010. Concurrently used drugs: NA. When starting to take Lupron Depot-ped the consumer reported the following symptoms:
    • Diarrhoea
    • Myositis
    • Injection Site Abscess
    • Abdominal Pain
    The patient was hospitalized. These side effects may potentially be related to Lupron Depot-ped.
    Protein Total Increased, Ascites, Lymphocyte Count Decreased, Abdominal Pain, Ammonia Increased, Constipation, Back Pain, Diarrhoea

    This is a Sorafenib (raf Kinase Inhibitor) side effect report of a 59-year-old patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: hepatic neoplasm malignant, who was treated with Sorafenib (raf Kinase Inhibitor) (dosage:Daily Dose 400 Mg, start time: Dec 27, 2011), combined with:
    • Lantus (Daily Dose 4 U)
    • Livact (Daily Dose 12.45 G)
    • Humalog (Daily Dose 12 U)
    • Amlodipine (5 Mg, Qd)
    • Sitagliptin Phosphate (Daily Dose 50 Mg)
    • Amaryl (Daily Dose 1 Mg)
    • Lasix (Daily Dose 20 Mg)
    • Trichlormethiazide (Daily Dose 2 Mg)
    , and developed a serious reaction and a Abdominal Pain side effect. The patient presented with:
    • Protein Total Increased
    • Ascites
    • Lymphocyte Count Decreased
    • Abdominal Pain
    • Ammonia Increased
    • Constipation
    • Back Pain
    • Diarrhoea
    which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Sorafenib (raf Kinase Inhibitor) treatment in patients suffering from hepatic neoplasm malignant, resulting in Abdominal Pain.
    Epigastric Discomfort, Abdominal Pain

    This report suggests a potential Aleve (caplet) Abdominal Pain side effect(s) that can have serious consequences. A 84-year-old female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): arthritis and used Aleve (caplet) (dosage: NA) starting NS. Soon after starting Aleve (caplet) the patient began experiencing various side effects, including:
    • Epigastric Discomfort
    • Abdominal Pain
    Drugs used concurrently:NA. Although Aleve (caplet) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Abdominal Pain, may still occur.
    Abdominal Pain, Hysterectomy, Polymenorrhoea

    This Abdominal Pain problem was reported by a consumer or non-health professional from GREECE. A 42-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): multiple sclerosis.On Oct 01, 2011 a consumer started treatment with Rebif (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Rebif, the patient experienced the following unwanted symptoms /side effects:
    • Abdominal Pain
    • Hysterectomy
    • Polymenorrhoea
    The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Abdominal Pain, may become evident only after a product is in use by the general population.
    Jaundice, Abdominal Pain, Hyperamylasaemia, Hyperlipasaemia

    This is a Victoza side effect report of a 71-year-old patient (weight: NA) from ITALY. The patient developed the following symptoms/conditions: type 2 diabetes mellitus and was treated with Victoza (dosage: 1.8 Mg, Qd) starting Jun 15, 2011. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
    • Jaundice
    • Abdominal Pain
    • Hyperamylasaemia
    • Hyperlipasaemia
    The patient was hospitalized. This opens a possibility that Victoza could cause Abdominal Pain and that some patients may be more susceptible.
    Asthenia, Vomiting, Abdominal Pain

    A 75-year-old patient (weight: NA) from UNITED STATES with the following symptoms: multiple myeloma started Revlimid treatment (dosage: 25 Mg, 1 In 1 D, Po) on Mar 08, 2011. Soon after starting Revlimid treatment, the consumer experienced several side effects, including:
    • Asthenia
    • Vomiting
    • Abdominal Pain
    . Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Revlimid side effects, such as Abdominal Pain.
    Toxicity To Various Agents, Tooth Disorder, Polycythaemia, Adrenal Disorder, Joint Stiffness, Musculoskeletal Stiffness, Asthenia, Urine Analysis Abnormal, Abdominal Pain

    This Abdominal Pain side effect was reported by a consumer or non-health professional from UNITED STATES. A female patient (weight:NA) experienced the following symptoms/conditions: osteopenia,pain.The patient was prescribed Aredia (dosage: NA), which was started on Jan 01, 2002. Concurrently used drugs:
    • Duragesic-100
    .When starting to take Aredia the consumer reported symptoms, such as:
    • Toxicity To Various Agents
    • Tooth Disorder
    • Polycythaemia
    • Adrenal Disorder
    • Joint Stiffness
    • Musculoskeletal Stiffness
    • Asthenia
    • Urine Analysis Abnormal
    • Abdominal Pain
    These side effects may potentially be related to Aredia. The patient was hospitalized.

    Discuss Abdominal Pain Side Effects

    Popular Pages